Infectociprocort (Ciprofloxacin, Fluocinolone Acetonide)

Infectociprocort acts on bacterial and inflammatory processes of the external ear, providing targeted therapy for ear conditions.

• Otitis externa: eliminates causative bacteria and reduces swelling and pain in the ear canal.
• Bacterial ear infection: eradicates susceptible pathogens while controlling local inflammation.
• External ear canal inflammation: alleviates redness, itching and discomfort associated with infection.

• Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and leading to bacterial cell death. Fluocinolone acetonide binds to glucocorticoid receptors, altering gene transcription to suppress the release of inflammatory mediators, thereby reducing edema, erythema and pain in the treated ear.

Infectociprocort may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Ear discomfort or burning sensation.
• Mild itching or irritation at the application site.
• Transient hearing changes such as muffled sounds.
• Dryness or flaking of the ear canal skin.
• Temporary increased ear discharge.
• Mild headache.

Serious or Rare Side Effects

• Allergic reaction including rash, swelling or anaphylaxis.
• Severe ototoxicity leading to permanent hearing loss.
• Perforation of the tympanic membrane.
• Secondary bacterial or fungal infection of the ear.
• Systemic fluoroquinolone effects such as tendon rupture.
• Central nervous system effects like seizures (rare).

Before using Infectociprocort, consider the following safety measures.

• Assess tympanic membrane integrity: avoid use if perforation is present.
• Allergy screening: do not use in patients with known ciprofloxacin or corticosteroid hypersensitivity.
• Monitor systemic fluoroquinolone effects: watch for tendon pain, joint issues, or neurological symptoms.
• Limit duration: follow prescriber guidance to reduce risk of resistance and local irritation.
• Use in children only when prescribed: pediatric safety data are limited.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Infectociprocort can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid)

• Antacids or supplements containing magnesium/aluminum: reduce ciprofloxacin absorption.
• Warfarin: may increase bleeding risk.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of tendon injury.
• Systemic corticosteroids: may amplify immunosuppressive effects.
• Live vaccines: potential reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely)

• Other otic preparations: assess cumulative local irritation.
• CYP1A2 inhibitors (e.g., fluvoxamine): may increase ciprofloxacin levels.
• Diuretics (e.g., furosemide): monitor for electrolyte disturbances.
• Oral fluoroquinolones: avoid concurrent systemic exposure.
• Antihistamines: may mask early signs of allergic reaction.